SILVER OAK SECURITIES, INCORPORATED

Broker-Dealer

Position in GILD — Gilead Sciences, Inc.

CIK 1080576 JACKSON, TN

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$460,003

-$71,554 QoQ

Shares Held

3,641

-4.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#1,411

of 2,266 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SILVER OAK SECURITIES, INCORPORATED holds $18,688,725 across 10 Drug Manufacturers - General names. GILD ranks #8 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	25,544	$6,427,892
2	LLY	ELI LILLY & Co	4,636	$5,560,557
3	JNJ	Johnson & Johnson	10,822	$2,748,463
4	MRK	Merck & Co., Inc.	9,556	$1,227,946
5	NVO	Novo Nordisk A S	12,911	$618,953
6	BMY	Bristol Myers Squibb Co	9,134	$526,301
7	AMGN	Amgen Inc	1,418	$513,486
8	GILD	Gilead Sciences, Inc. This page	3,641	$460,003

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$460,003	3,641	-4.5%	Shares	Sole	2026-08-07
2026-03-31	$531,557	3,814	+1.3%	Shares	Sole	2026-04-20
2025-12-31	$461,993	3,764	-0.5%	Shares	Sole	2026-01-15
2025-09-30	$420,024	3,784	+1.2%	Shares	Sole	2025-10-21
2025-06-30	$414,653	3,740	-19.7%	Shares	Sole	2025-07-11
2023-03-31	$386,225	4,655	-4.3%	Shares	Sole	2023-05-05
2022-12-31	$417,488	4,863	-29.8%	Shares	Sole	2023-02-02
2022-06-30	$428,219	6,928	+4.4%	Shares	Sole	2022-08-15
2022-03-31	$394,450	6,635	—	Shares	Sole	2022-05-10
No filing history on record for this holder in this stock.